HLL Lifecare, a Kerala-based PSU, produces 221.7 crore condoms annually, solidifying its position as a leading global manufacturer. With ei...

Beware of becoming overdependent on contraceptives!

The use of progestogen-only contraceptives has increased substantially in recent years.

Hailey Bieber has publicly discussed ovarian cysts as a health problem. In an Instagram post, the model addressed the condition, which caus...

The company's current portfolio consists of 137 products authorised for distribution at the US marketplace and 61 Abbreviated New Drug Appl...

There is no evidence to show that contraceptive pills may harm mental health.

The move, earlier notified by NPPA at the beginning of the month, is expected to keep the impact of GST on life-saving medicines at a minim...

Bangladesh, which has a robust family-planning programme, distributes sukhi pills for free which have also made their way across the border...

Morning-after pills, doctors say, should be used to prevent pregnancy only in the case of an unexpected lapse such as a condom break.

The two organisations stressed that the potential of private healthcare sector needs to be tapped to achieve the ambitious Family Planning ...

Delhi High Court today revoked two orders of the pharma pricing authority to cap condom prices, saying these were "illegal and unsustainabl...

The court said in response that the government can impose conditions on the companies to maintain the same proportion of manufacture as of ...

"Given complex manufacturing processes and high investments, the competition is low in the segment and typically attracts only a few player...

The country's second-largest pharmaceuticals company, Cipla, is in talks with an international health group to expand its contraceptive pil...

Pfizer recalled 1 mn birth-control packs after discovering that pills were mixed up inside the packages, possibly putting women at risk.

Drugmakers promoting their brands through awareness campaigns have not gone down well with the country's drug regulator, who had banned suc...

Baring Private Equity Partners (India) is the front-runner to buy about 15% stake in Mumbai-based drugmaker Famy Care for around $40 millio...